Inhaled glucocorticosteroids in otorhinolaryngology
Currently, there is a wide introduction of inhaled glucocorticosteroids (InGCS) into otorhinolaryngological practice, which is explained by their local impact and low bioavailability, as well as proven high therapeutic effectiveness in various forms of rhinosinusitis (RS), adenoiditis and allergic...
Main Authors: | T. I. Garashchenko, G. D. Tarasova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Remedium Group LLC
2020-03-01
|
Series: | Медицинский совет |
Subjects: | |
Online Access: | https://www.med-sovet.pro/jour/article/view/5538 |
Similar Items
-
Allergic rhinitis: current assessment of medical and social aspects and methods of treatment. intranasal corticosteroids in the treatment of rhinitis
by: S. V. Tsarev
Published: (2018-10-01) -
ALLERGIC RHINITIS: EFFICIENT THERAPEUTIC OPPORTUNITIES
by: M. L. Derbeneva, et al.
Published: (2018-01-01) -
The specific use of budesonide in the treatment of allergic rhinitis
by: S. V. Tsarev
Published: (2016-12-01) -
Benefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis: an EAACI position paper
by: Valerie Hox, et al.
Published: (2020-01-01) -
THE ANALYSIS OF THE LIPETSK PHARMACEUTICAL MARKET OF NASAL GLUCOCORTICOSTEROID
by: K. V. Danilova, et al.
Published: (2015-03-01)